GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (LTS:0Y5E) » Definitions » Cyclically Adjusted PS Ratio

Perrigo Co (LTS:0Y5E) Cyclically Adjusted PS Ratio : 0.71 (As of Jun. 05, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Perrigo Co Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Perrigo Co's current share price is $27.04. Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was $37.96. Perrigo Co's Cyclically Adjusted PS Ratio for today is 0.71.

The historical rank and industry rank for Perrigo Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

LTS:0Y5E' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.69   Med: 1.8   Max: 7.64
Current: 0.73

During the past years, Perrigo Co's highest Cyclically Adjusted PS Ratio was 7.64. The lowest was 0.69. And the median was 1.80.

LTS:0Y5E's Cyclically Adjusted PS Ratio is ranked better than
78.79% of 745 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs LTS:0Y5E: 0.73

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Perrigo Co's adjusted revenue per share data for the three months ended in Mar. 2024 was $7.864. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $37.96 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perrigo Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Perrigo Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Cyclically Adjusted PS Ratio Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.33 1.10 0.91 0.85

Perrigo Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 0.89 0.83 0.85 0.85

Competitive Comparison of Perrigo Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Perrigo Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perrigo Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perrigo Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Perrigo Co's Cyclically Adjusted PS Ratio falls into.



Perrigo Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Perrigo Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=27.04/37.96
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perrigo Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Perrigo Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=7.864/120.9901*120.9901
=7.864

Current CPI (Mar. 2024) = 120.9901.

Perrigo Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 7.433 100.773 8.924
201409 7.080 100.474 8.526
201412 7.834 99.576 9.519
201503 7.451 99.975 9.017
201506 7.872 100.573 9.470
201509 9.154 100.274 11.045
201512 9.823 99.676 11.923
201603 9.659 99.676 11.724
201606 9.361 101.072 11.206
201609 8.804 100.274 10.623
201612 9.271 99.676 11.253
201703 8.315 100.374 10.023
201706 8.639 100.673 10.382
201709 8.689 100.474 10.463
201712 9.036 100.075 10.924
201803 8.607 100.573 10.354
201806 8.554 101.072 10.240
201809 8.247 101.371 9.843
201812 8.775 100.773 10.535
201903 8.623 101.670 10.262
201906 8.418 102.168 9.969
201909 8.707 102.268 10.301
201912 2.597 102.068 3.078
202003 7.890 102.367 9.325
202006 6.900 101.769 8.203
202009 7.289 101.072 8.725
202012 7.727 101.072 9.250
202103 7.504 102.367 8.869
202106 7.344 103.364 8.596
202109 7.793 104.859 8.992
202112 8.252 106.653 9.361
202203 8.019 109.245 8.881
202206 8.334 112.779 8.941
202209 8.174 113.504 8.713
202212 8.570 115.436 8.982
202303 8.760 117.609 9.012
202306 8.734 119.662 8.831
202309 8.209 120.749 8.225
202312 8.532 120.749 8.549
202403 7.864 120.990 7.864

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perrigo Co  (LTS:0Y5E) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Perrigo Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co (LTS:0Y5E) Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co (LTS:0Y5E) Headlines

No Headlines